THERE'S NO CARE LIKE HOME
LIVE

Serial Number

98170615

Owner

REIMAGINE CARE, INC.

Attorney

Benjamin W. Janke

Filing Date

Sep 8, 2023

Add to watchlist:

No watchlists yet
View on USPTO

THERE'S NO CARE LIKE HOME Trademark

Serial Number: 98170615 • Registration: 7605004

THERE'S NO CARE LIKE HOME is a trademark filed by REIMAGINE CARE, INC. on September 8, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

REIMAGINE CARE, INC. (3 trademarks)

20 BURTON HILLS BLVD., STE 150
NASHVILLE, TN 37215

Entity Type: 03

Trademark Details

Filing Date

September 8, 2023

Registration Date

December 17, 2024

Published for Opposition

October 15, 2024

Goods & Services

Arranging of contracts for clinical trials and value-based care contracts with third parties

Providing personal support services for patients and families of patients undergoing cancer treatment, namely, emotional counseling and emotional support through volunteers in the community who include cancer survivors, as well as family members and friends of cancer patients

Analysis of oncology medical information for the treatment of cancer in the home on behalf of patients and cancer care providers, namely, medical record analysis of value-based care, care coordination, decision-making services, and insights in the nature of severity of patients' symptoms, as well as the evaluation of medical information from oncology clinical research studies for determining patient access and participation in clinical trials for the treatment of cancer; medical services in the field of oncology, namely, providing oncology infusion therapy and oral oncolytic in alternative settings; medical services, namely, providing real-time symptom management and telemedicine triage via a dedicated multi-disciplinary oncology care team to optimize adverse cancer patient events and reactions to cancer

Platform as a service (PAAS) featuring computer software platforms for providing oncology hospital at home technology-enabled services in the nature of monitoring medication administration and dosage, assessing and reporting on pain levels for supporting oncologists and other healthcare providers in delivering high-quality, lower-cost, patient-centric cancer care; conducting scientific research in the nature of clinical trials for others relating to medical devices and pharmaceuticals in the field of cancer diagnosis and treatment, namely, partnering with pharmaceutical companies and clinical research organizations (CROs) to administer and monitor oncology clinical trials at patients' homes, and provide clinical trial access to diverse patient populations for clinical trial participation, accelerate trial completion, and lower trial costs; Platform as a service (PAAS) featuring computer software platforms for monitoring, analyzing, assessing, transmitting patient medical and healthcare data to inform cancer care delivery optimization to patients and cancer care providers through a value-based care logistics management platform to efficiently and effectively manage workforce staffing, patient care, and pharmaceutical supplies required in alternative cancer delivery models; Platform as a service (PAAS) featuring computer software platforms for providing a comprehensive oncology clinical management solution, namely, medication administration and management, supportive care, lab testing, pain management, day-after-chemo injection of colony-stimulating factor drugs, advanced care planning, and at-home palliative care; Platform as a service (PAAS) featuring computer software platforms for providing cancer patients extensive cancer care navigation services in the nature of providing coordinated care by assessing, triaging, follow-up and supporting patients 24/7 and on-demand, for keeping patients with compromised immune function out of institutional settings and treating them in the convenience of their homes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 15, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 7, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 13, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 13, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 13, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 13, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 13, 2024 CNRT
ASSIGNED TO EXAMINER
May 3, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2023 NWOS
NEW APPLICATION ENTERED
Sep 12, 2023 NWAP